Form 4: VolitionRx Executive Ann-Louise Batchelor Receives Stock Units in Lieu of Cash Compensation

Ann-Louise Batchelor, Group Chief Marketing Officer at VolitionRx, was granted 13,731 restricted stock units (RSUs) in lieu of cash compensation on September 1, 2024.

Summary

• On September 1, 2024, Ann-Louise Batchelor, Group Chief Marketing Officer of VolitionRx Ltd, received 13,731 restricted stock units (RSUs) under the company's 2015 Stock Incentive Plan.
• These RSUs were granted in lieu of cash compensation.
• The RSUs vest partially in three equal installments of 4,577 units on September 1, 2024, October 1, 2024, and November 1, 2024.
• The remaining RSUs vest in a single installment on June 1, 2025, subject to continued service.
• Upon vesting and settlement, Batchelor will receive common stock shares equal to the number of vested RSUs.
• Following the transaction, Batchelor directly owns 113,280 shares of common stock and indirectly owns 29,406 shares through her spouse.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns executive interests with shareholders.

Positives

• The grant of RSUs aligns Batchelor's interests with those of the shareholders, incentivizing her to contribute to the company's long-term success.
• Using RSUs instead of cash compensation can help the company conserve cash.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

This type of equity compensation is common for executives in publicly traded companies to align their interests with shareholders.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns executive compensation with company performance.
• Employees may see this as a standard practice for executive compensation.

Next Steps

• Batchelor will receive shares of common stock as the RSUs vest over time, contingent on continued service.

Key Dates